Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)
about
In Vitro-In Vivo Dose Response of Ursolic Acid, Sulforaphane, PEITC, and Curcumin in Cancer Prevention.Role of MSC-derived galectin 3 in the AML microenvironment.Potential signaling pathways as therapeutic targets for overcoming chemoresistance in mucinous ovarian cancer.Parallels between hematopoietic stem cell and prostate cancer disseminated tumor cell regulation.Androgen action in prostate function and disease.Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review).Periostin secreted by cancer-associated fibroblasts promotes cancer stemness in head and neck cancer by activating protein tyrosine kinase 7lncRNA GAS5 Reverses EMT and Tumor Stem Cell-Mediated Gemcitabine Resistance and Metastasis by Targeting miR-221/SOCS3 in Pancreatic CancerCD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor ProgressionSoft Tissue Sarcoma Cancer Stem Cells: An OverviewBenzylamine and Thenylamine Derived Drugs Induce Apoptosis and Reduce Proliferation, Migration and Metastasis Formation in Melanoma CellsUsing Zebrafish to Study Collective Cell Migration in Development and Disease
P2860
Q47271539-FBB2C52C-F53A-4423-8A00-1C0248BB743AQ52588202-3EB53016-5F9D-49CE-AF83-A6FA42F0B77DQ52643559-77F93F3A-DBD7-4BFF-804C-DCD1670FDFB9Q52729491-493ACD2F-5E2D-44FB-BD38-96B7BB9C1317Q55251761-0F9857A3-0DE5-41A7-83A2-41DCDE8E509CQ55509442-132C080A-E334-4F9B-8660-045E0024229EQ57801748-922D2A5A-B02C-4304-A935-0AFDB434D44CQ58581562-3C2BDE2B-D42E-4922-BC30-60965337159CQ58697956-3A9BC144-9D4E-4CAB-BE96-31695F4AAA71Q58707604-0612BFCE-0BE9-4F46-B951-B9B224D2751FQ58712892-D5AA3D98-FDAE-436D-8272-29CC1C844D76Q58769328-12D09D6C-4CA9-4599-9011-991E58444356
P2860
Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Canonical and non-canonical WN ...... and tumor plasticity (Review)
@en
Canonical and non-canonical WN ...... and tumor plasticity (Review)
@nl
type
label
Canonical and non-canonical WN ...... and tumor plasticity (Review)
@en
Canonical and non-canonical WN ...... and tumor plasticity (Review)
@nl
prefLabel
Canonical and non-canonical WN ...... and tumor plasticity (Review)
@en
Canonical and non-canonical WN ...... and tumor plasticity (Review)
@nl
P2860
P921
P356
P1476
Canonical and non-canonical WN ...... and tumor plasticity (Review)
@en
P2093
Masaru Katoh
P2860
P304
P356
10.3892/IJO.2017.4129
P5008
P577
2017-09-19T00:00:00Z
2017-11-01T00:00:00Z